pyrrole-based kinesin spindle protein inhibitors (Bayer AG)

N/A

Report date: 2025/06/11 10:48:17

Base Information

Drug Namepyrrole-based kinesin spindle protein inhibitors (Bayer AG)

Drug Alias NameTWEAK receptor kinesin spindle protein antibody drug conjugate (Bayer)TWEAKR-KSP ADC (Bayer)BAY-333BAY-380

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionKinesin-like protein 1 inhibitors

TargetsKinesin-like protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Develop Information

Active CompaniesBayer AG

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A